Journal Editors Slam Industry-Funded Device Approval Studies
This article was originally published in The Gray Sheet
Executive Summary
The editors of three premier peer-reviewed medical journals say two widely circulated reports criticizing FDA's medical device review process are deeply flawed, biased and should play no part in discussions over FDA regulatory reforms.
You may also be interested in...
Institute Of Medicine On 510(k) Review Program: Dump It
The Institute of Medicine committee charged with reviewing FDA's 510(k) device pre-market review program is urging the agency to ditch the 35-year-old program and start fresh.
Institute Of Medicine On 510(k) Review Program: Dump It
The Institute of Medicine committee charged with reviewing FDA's 510(k) device pre-market review program is urging the agency to ditch the 35-year-old program and start fresh.
In User Fee Talks, FDA Investigates Pre-market Review Delays
As FDA user fee negotiations move ahead, the agency is conducting a root cause analysis to determine why the time it takes to complete pre-market device reviews is increasing.